SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V}

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: T-Lo Greens who wrote (262)3/10/2000 12:07:00 AM
From: BRAVEHEART  Read Replies (1) of 423
 
Hi Tony,

GLGC is a good company fundamentally. How does one go about valuating such an operation. Well if you asked me at $4 when I was trading it I would have said $175 in five years at best. However Biotech has become the internet of 2,000. So it depends on the mood of the market. That mood is not obvious & no one source can be trusted to convey that general tenor across the sector. Tuck is right there is some violent correcting in the sector. That creates an avalanche of shorting & profit taking.

Realize the summer is typically a cyclically down period for Biotech. Hence I would concur with tuck that $70 is resistant for the moment. However my guess is it trades to the mid $40's by mid to late summer. If I were short I would cover in the $70's Let it breathe and decide from there.

Learn to read the charts. Three month MACD looks to be controlling. Trade based on stokes once you see leveling support not until then.

clearstation.com

Realize it is dropping & gapping fast.

clearstation.com

I believe GLGC did a secondary. They could be selling into this run up. I don't know the secondary issue price that would help. Check the short position.

BEST WISHES
Jeffrey
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext